Switch to:
Nivalis Therapeutics Inc (NAS:NVLS)
EV/Revenue
(As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Nivalis Therapeutics Inc's enterprise value is $207.21 Mil. Nivalis Therapeutics Inc's revenue for the trailing twelve months (TTM) ended in Jun. 2015 was $0.00 Mil. Therefore, Nivalis Therapeutics Inc's EV/Revenue ratio for today is .

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Nivalis Therapeutics Inc's stock price is $15.21. Nivalis Therapeutics Inc's revenue per share for the trailing twelve months (TTM) ended in Jun. 2015 was $0.00. Therefore, Nivalis Therapeutics Inc's P/S Ratio for today is .


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nivalis Therapeutics Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=207.210/0
=

Nivalis Therapeutics Inc's current Enterprise Value is $207.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nivalis Therapeutics Inc's Revenue for the trailing twelve months (TTM) ended in Jun. 2015 was $0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nivalis Therapeutics Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=15.21/0
=

Nivalis Therapeutics Inc's share price for today is $15.21.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nivalis Therapeutics Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Jun. 2015 was $0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Nivalis Therapeutics Inc Annual Data

Dec12Dec13Dec14
ev2rev 0.000.000.000.000.000.000.000.000.000.00

Nivalis Therapeutics Inc Semi-Annual Data

Dec12Dec13Mar14Dec14Mar15Jun15
ev2rev 0.000.000.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK